Please login to the form below

Not currently logged in
Email:
Password:

Polpharma

This page shows the latest Polpharma news and features for those working in and with pharma, biotech and healthcare.

Novartis expands its generics franchise with natalizumab biosimilar

Novartis expands its generics franchise with natalizumab biosimilar

Says affordability is a challenge to access. Sandoz, Novartis’ generics unit, has agreed to license a biosimilar of Biogen’s Tysabri for multiple sclerosis from Polpharma Biologics. . ... Polpharma will maintain the responsibilities for the

Latest news

More from news
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest Intelligence

  • Building a bright future Building a bright future

    level. High value. “It has been very smart to combine global and local aspirations,” adds Glinka, who joined the company in 2013 after serving as CEO of Poland’s Polpharma, a

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Dr Maurice Chagnaud appointed as new CEO of Polpharma Dr Maurice Chagnaud appointed as new CEO of Polpharma

    Will take the reins at the Polish pharmaceutical group week. Polish pharmaceutical group Polpharma has appointed Dr Maurice Chagnaud as its new CEO. ... Jerzy Starak, chairman of Polpharma's supervisory board, said: “Polpharma's strategic goal is to

  • Mylan hires Jacek Glinka as European head Mylan hires Jacek Glinka as European head

    He will join the firm from Poland’s Polpharma. US pharma company Mylan has named Jacek Glinka as president of its European business. ... During this time, he helped expand Polpharma from a small local biopharma to one that now stretches across Central

More from appointments
Approximately 2 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
IGNIFI

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....

Infographics